hRSD results for the study eyes in the non-converters [SE(NC); final visit], the study eyes in the converters [SE(C); conversion visit] and eyes in which nAMD has been diagnosed tested around the time of the first antiVEGF injection (FE).

Datapoints indicate individual test results, the mean (±95% CI) also shown for each group. The grey horizontal line and region is the mean (±95% CI) hRSD result for healthy eyes, taken from Ku et al (2016). The one-way ANOVA result (comparing the three patient groups) and post-hoc test results (Tamhane’s T2) are shown for these data.